160 related articles for article (PubMed ID: 29641580)
1. Clinicopathological analysis of polyploid diffuse large B-cell lymphoma.
Shimono J; Miyoshi H; Kiyasu J; Kamimura T; Eto T; Miyagishima T; Nagafuji K; Seto M; Teshima T; Ohshima K
PLoS One; 2018; 13(4):e0194525. PubMed ID: 29641580
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of diffuse large B-cell lymphoma with polyploidy.
Shimono J; Miyoshi H; Seto M; Teshima T; Ohshima K
Pathol Int; 2017 Jan; 67(1):17-23. PubMed ID: 27868293
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics and Prognostic Significance of Cytogenetic Abnormalities in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement].
Liu W; Lyu R; Huang WY; Li CW; Liu H; Li J; Zou DH; Qiu LG; Yi SH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):761-765. PubMed ID: 28641631
[TBL] [Abstract][Full Text] [Related]
4. Karyotyping of diffuse large B-cell lymphomas: loss of 17p is associated with poor patient outcome.
Fiskvik I; Aamot HV; Delabie J; Smeland EB; Stokke T; Heim S; Holte H
Eur J Haematol; 2013 Oct; 91(4):332-8. PubMed ID: 23859481
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival.
Yoshioka T; Miura I; Kume M; Takahashi N; Okamoto M; Ichinohasama R; Yoshino T; Yamaguchi M; Hirokawa M; Sawada K; Nakamura S
Genes Chromosomes Cancer; 2005 Feb; 42(2):149-57. PubMed ID: 15543600
[TBL] [Abstract][Full Text] [Related]
6. Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome.
Tzankov A; Gschwendtner A; Augustin F; Fiegl M; Obermann EC; Dirnhofer S; Went P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2125-32. PubMed ID: 16609025
[TBL] [Abstract][Full Text] [Related]
7. Chromosome abnormalities in diffuse large B-cell lymphomas: analysis of 231 Chinese patients.
Zhao X; Fan R; Lin G; Wang X
Hematol Oncol; 2013 Sep; 31(3):127-35. PubMed ID: 23135954
[TBL] [Abstract][Full Text] [Related]
8. [THE PROGNOSTIC IMPACT OF CHROMOSOMAL ABERRATIONS IN TUMOR TISSUE BIOPSIES FROM PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA].
Fahoum I; Ziv M; Bar-El H; Attias D; Tadmor T
Harefuah; 2016 Jan; 155(1):45-9, 66. PubMed ID: 27012075
[TBL] [Abstract][Full Text] [Related]
9. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
[TBL] [Abstract][Full Text] [Related]
10. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
Le Gouill S; Talmant P; Touzeau C; Moreau A; Garand R; Juge-Morineau N; Gaillard F; Gastinne T; Milpied N; Moreau P; Harousseau JL; Avet-Loiseau H
Haematologica; 2007 Oct; 92(10):1335-42. PubMed ID: 18024371
[TBL] [Abstract][Full Text] [Related]
11. BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma.
Obermann EC; Csato M; Dirnhofer S; Tzankov A
J Clin Pathol; 2009 Oct; 62(10):903-7. PubMed ID: 19783718
[TBL] [Abstract][Full Text] [Related]
12. Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment.
Obermann EC; Csato M; Dirnhofer S; Tzankov A
J Clin Pathol; 2009 Aug; 62(8):754-6. PubMed ID: 19638549
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time.
Chang ST; Lu YH; Lu CL; Weng SF; Lin SH; Kuo SY; Chuang YT; Takeuchi K; Ohshima K; Chuang SS
J Clin Pathol; 2014 Apr; 67(4):326-32. PubMed ID: 24218026
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS).
Carreras J; Kikuti YY; Beà S; Miyaoka M; Hiraiwa S; Ikoma H; Nagao R; Tomita S; Martin-Garcia D; Salaverria I; Sato A; Ichiki A; Roncador G; Garcia JF; Ando K; Campo E; Nakamura N
Histopathology; 2017 Mar; 70(4):595-621. PubMed ID: 27775850
[TBL] [Abstract][Full Text] [Related]
15. TRPM4 expression is associated with activated B cell subtype and poor survival in diffuse large B cell lymphoma.
Loo SK; Ch'ng ES; Md Salleh MS; Banham AH; Pedersen LM; Møller MB; Green TM; Wong KK
Histopathology; 2017 Jul; 71(1):98-111. PubMed ID: 28248435
[TBL] [Abstract][Full Text] [Related]
16. Primary adrenal diffuse large B cell lymphoma: a clinicopathological and molecular study from China.
Zhang J; Sun J; Feng J; Luo Y; Ling Q; Wu S; Zeng X; Liang Z
Virchows Arch; 2018 Jul; 473(1):95-103. PubMed ID: 29802470
[TBL] [Abstract][Full Text] [Related]
17. New chromosome abnormalities and lack of BCL-6 gene rearrangements in Argentinean diffuse large B-cell lymphomas.
Cerretini R; Noriega MF; Narbaitz M; Slavutsky I
Eur J Haematol; 2006 Apr; 76(4):284-93. PubMed ID: 16519699
[TBL] [Abstract][Full Text] [Related]
18. A spindle cell variant of diffuse large B-cell lymphoma is characterized by T-cell/myofibrohistio-rich stromal alterations: analysis of 10 cases and a review of the literature.
Kimura Y; Arakawa F; Kiyasu J; Miyoshi H; Yoshida M; Ichikawa A; Nakashima S; Ishibashi Y; Niino D; Sugita Y; Ishiyama K; Higuchi M; Takasaki Y; Shimomura T; Koike C; Kuwahara N; Fujikawa K; Ohshima K
Eur J Haematol; 2012 Oct; 89(4):302-10. PubMed ID: 22738254
[TBL] [Abstract][Full Text] [Related]
19. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma.
Stefancikova L; Moulis M; Fabian P; Vasova I; Zedek F; Ravcukova B; Muzik J; Kuglik P; Vranova V; Falkova I; Hrabalkova R; Smardova J
Int J Oncol; 2011 Dec; 39(6):1413-20. PubMed ID: 21874232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
